person · Reporting owner

Carroll Patrick Harrison

Disclosed activity across 1 company

Tapewire entity: 22012
SEC CIK: 0001839736

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Hims & Hers Health, Inc.HIMS · Entity 1878	Chief Medical Officer	August 14, 2026	August 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Hims & Hers Health, Inc.

Report date August 14, 2026 · Filed August 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	197,847	Ending reported balance After 2026-08-14 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2026-08-14 · Exercise / conversion · Acquired 260 · Balance 182,121 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Row 2 · 2026-08-14 · Exercise / conversion · Acquired 25,927 · Balance 208,048 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Row 3 · 2026-08-14 · Tax withholding · Disposed 10,201 · Balance 197,847 F2: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-08-14 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-08-14 · Exercise / conversion · Disposed 260 · Balance 0 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $7,912 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	8,149	Reported balance After 2026-08-14 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-08-14 · Exercise / conversion · Disposed 8,149 · Balance 8,149 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the Company's quarterly vesting dates occurring thereafter.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	29,038	Reported balance After 2026-08-14 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2026-08-14 · Exercise / conversion · Disposed 4,839 · Balance 29,038 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	35,331	Reported balance After 2026-08-14 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2026-08-14 · Exercise / conversion · Disposed 3,533 · Balance 35,331 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	131,678	Reported balance After 2026-08-14 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2026-08-14 · Exercise / conversion · Disposed 9,406 · Balance 131,678 F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F7: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

F2: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.

F3: The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $7,912 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

F4: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the Company's quarterly vesting dates occurring thereafter.

F5: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.

F6: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.

F7: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	155	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 8 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155 Underlying: Class A Common Stock · 155 shares Expires not disclosed F4 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	5,184	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 7 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,184 Underlying: Class A Common Stock · 5,184 shares Expires not disclosed F4 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. F4 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2021, subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	352	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 6 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 Underlying: Class A Common Stock · 352 shares Expires not disclosed F3 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F3 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	17,724	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 5 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,724 Underlying: Class A Common Stock · 17,724 shares Expires not disclosed F3 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F3 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. F3 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after March 15, 2020, subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	220	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 4 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220 Underlying: Class A Common Stock · 220 shares Expires not disclosed F2 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F2 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F2 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	11,077	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 3 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,077 Underlying: Class A Common Stock · 11,077 shares Expires not disclosed F2 · derivative.exercise_price: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F2 · derivative.exercise_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. F2 · derivative.expiration_date: The Reporting Person was granted RSUs which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of December 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	132	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 2 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132 Underlying: Class A Common Stock · 132 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document
March 29, 2021 Filed Mar 31, 2021 21:27 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	6,646	$0.00	$0.00	Disclosure SEC source: 0000899243-21-014246 · doc4.xml · derivative · entry 1 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,646 Underlying: Class A Common Stock · 6,646 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of September 15, 2019. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document
January 20, 2021 Filed Jan 23, 2021 02:32 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	2,614	$0.00	$0.00	Disclosure SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 6 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,614 Underlying: Class A Common Stock · 2,614 shares Expires not disclosed F7 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs"). F8 · derivative.exercise_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. F8 · derivative.expiration_date: The Earn Out RSUs were received in exchange for shares of Legacy Hims RSUs. Subject to the satisfaction of time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out conditions are not met during the Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. Read SEC document
January 20, 2021 Filed Jan 23, 2021 02:32 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantRestricted Stock Unit · Derivative	26,725	$0.00	$0.00	Disclosure SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 5 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,725 Underlying: Class A Common Stock · 26,725 shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs"). F6 · derivative.exercise_date: The New Hims RSUs were received in exchange for 59,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service with the Company. The RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). F6 · derivative.expiration_date: The New Hims RSUs were received in exchange for 59,000 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period in substantially equal quarterly installments beginning March 15, 2021, with 6.25% of the RSUs vesting on each of March 15, June 15, September 15 and December 15, subject to the individual's continuous service with the Company. The RSU is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable RSU Agreement). Read SEC document
January 20, 2021 Filed Jan 23, 2021 02:32 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantStock Option (right to buy) · Derivative	181,192	$0.00 Strike: $2.43	$0.00	Disclosure SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 4 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,192 Underlying: Class A Common Stock · 181,192 shares Expires 2030-05-12 F4 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 400,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement). Read SEC document
January 20, 2021 Filed Jan 23, 2021 02:32 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantStock Option (right to buy) · Derivative	113,245	$0.00 Strike: $2.43	$0.00	Disclosure SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 3 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,245 Underlying: Class A Common Stock · 113,245 shares Expires 2030-05-12 F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 250,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares shall vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning December 5, 2019. Read SEC document
January 20, 2021 Filed Jan 23, 2021 02:32 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantStock Option (right to buy) · Derivative	67,947	$0.00 Strike: $1.75	$0.00	Disclosure SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 2 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,947 Underlying: Class A Common Stock · 67,947 shares Expires 2029-07-08 F2 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 150,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $0.79, in connection with the Merger. 1/4 of the shares subject to the Stock Option vest on the 12 month anniversary of the vesting commencement date and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date, beginning June 17, 2019. Read SEC document
January 20, 2021 Filed Jan 23, 2021 02:32 UTC	Hims & Hers Health, Inc. HIMS · Entity 1878	GrantStock Option (right to buy) · Derivative	52,998	$0.00 Strike: $9.41	$0.00	Disclosure SEC source: 0000899243-21-003106 · doc4.xml · derivative · entry 1 Carroll Patrick Harrison · CIK 0001839736 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,998 Underlying: Class A Common Stock · 52,998 shares Expires 2030-12-22 F1 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase 117,000 shares of Class A Common Stock of Hims, Inc., with an exercise price of $4.26, in connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning December 16, 2020. The Stock Option is also subject to acceleration in the event the Reporting Person is subject to a qualifying involuntary termination of employment and/or Change of Control (as such term is defined in the applicable Stock Option Agreement). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.